A HER2-targeting antibody-drug conjugate, trastuzumab deruxtecan (DS-8201a), enhances antitumor immunity in a mouse model
Iwata, Tomomi Nakayama, Ishii, Chiaki, Ishida, Saori, Ogitani, Yusuke, Wada, Teiji, Agatsuma, ToshinoriLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-0749
Date:
April, 2018
File:
PDF, 3.12 MB
english, 2018